Recent Activity Alert
The bill titled "To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information" was introduced in the 119th Congress on April 14, 2026. The bill aims to modify the Federal Food, Drug, and Cosmetic Act to mandate drug labeling that discloses details of the original manufacturer and supply chain, potentially enhancing transparency and traceability in the pharmaceutical industry.
How will this impact me? ✨
6
2
2
2